stockportfolio.pro
Stocks / BMY vs CVS
BMY vs CVS
Bristol-Myers Squibb Company and CVS Health Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Bristol-Myers Squibb Company (BMY) | CVS Health Corporation (CVS) | |
|---|---|---|
| Market cap | $115.3B | $123.8B |
| Revenue (latest FY) | $48.19B | $402.07B |
| Net income (latest FY) | $7.05B | $1.77B |
| Revenue growth (5y CAGR) | 2.5% | 8.4% |
| Net margin | 14.6% | 0.4% |
| Return on equity | 38.2% | 2.4% |
| P/E ratio | 15.8 | 42.6 |
| Dividend yield | 4.5% | 2.7% |
| Profitable years (of last 10) | 8 | 9 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open BMY — free Open CVS — freeFrequently asked questions
Which is bigger, BMY or CVS?
CVS Health Corporation is larger by market capitalization — $123.8B versus $115.3B.
Which grows faster, BMY or CVS?
Over the last five fiscal years, CVS Health Corporation grew revenue faster — 8.4%/yr versus 2.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.